AXLA Axcella Health Inc.

Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/08/2019
Outstanding shares:  38,916,570
Average volume:  86,153
Market cap:   $106,242,236
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05454B105
ISIN:        US05454B1052
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.77
PS ratio:   0.00
Return on equity:   -174.14%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy